Cointime

ARPHION

company

About

Arphion provides oral healthcare non-invasive diagnostic and treatment products for benign diseases such as oral cancer.

  • 11 - 50

Highlights

Total Funding Amount
$225K
Funding Rounds
1
Investors
1

Details

Last Funding Type
Grant
Last Funding Money Raised
$225K
Industries
Consulting,Health Care,Health Diagnostics
Number Of Employee
11 - 50
Operating Status
Active

Arphion creates non-invasive diagnostics for oral cancers and other benign diseases. They utilize miRNA markers from cheek swabs to diagnose oral squamous cell carcinomas.

Arphion provides its clients with tests as a Laboratory Developed Test (LDT) through a CLIA-certified laboratory to market their products without submission to the FDA for approval or clearance.

Arphion was founded by Dr. Guy Adami, Ph.D. in Illinois, United States.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$225K
ARPHION has raised a total of $225K in funding over 2 rounds. Their latest funding was raised on Mar 3, 2013 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 3, 2013 Grant $225K 1 National Science Foundation — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
ARPHION is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant
Cointime
Содержание
компания